高血压患病率和覆盖率以及智力障碍:系统性审查和元分析
Rodrigo Vargas-Fernández1, Akram Hernández-Vásquez2, Hannah Kuper3
1London School of Hygiene and Tropical Medicine, London, UK.
Disability and health journal
|September 18, 2025
概括
智力障碍 (ID) 的成年人有类似的高血压患病率,但治疗覆盖率较低. 由于研究的局限性和ID的诊断变异性,需要进一步的研究.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 关于残疾人的研究.
背景情况:
- 智力障碍 (ID) 患者经常面临健康差异.
- 患有ID的成年人中高血压的患病率和治疗覆盖率差距尚不清楚.
研究的目的:
- 进行一个元分析,估计高血压的患病率和治疗覆盖率在成年人和没有ID.
- 确定影响这些估计的因素.
主要方法:
- 在多个数据库 (MEDLINE,Embase等) 中进行系统搜索. 在2024年6月之前.
- 包括对高血压和治疗覆盖率的观察和干预研究.
- 随机效应的元分析,以计算聚合的流行率 (PR) 和95%置信区间 (CI).
- 使用纽卡斯尔-太华尺度进行偏差风险评估.
主要成果:
- 高血压的聚合PR为0.71 (95% CI:0.47-1.05),表明患病率类似.
- 高血压治疗覆盖率的聚合PR为0.61 (95% CI:0.47-0.81),显示了成年人患有ID的覆盖率较低.
- 观察到显著的异质性,样本大小和ID诊断方法是变化的主要来源.
- 大多数研究都有高偏差风险,并且缺乏对年龄等混因素的调整.
结论:
- 患有ID的成年人表现出类似的高血压患病率,但与他们的非残疾同龄人相比,治疗覆盖率明显较低.
- 由于方法上的局限性,研究结果需要谨慎解释,包括混和不一致的ID诊断.
- 未来的研究应该专注于标准化的ID评估和对混因子的强有力的调整,以澄清这一群体的高血压管理.
相关概念视频
Intellectual Disability
647
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
647
Hypertension III: Clinical Manifestations and Diagnostic Studies
471
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
471
Hypertension II: Pathophysiology
803
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
803
Hypertension I: Introduction
745
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
745
Hypertension and Regulation of Blood Pressure
3.8K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Hypertension IV: Drug Therapy and Lifestyle Modifications
624
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
624
